As the panelists suggest methods to help control the costs of agents for the treatment of multiple sclerosis (MS) and improve patient care, Gary M. Owens, MD, explains that the US needs to aggressively review a drug’s cost versus its value and make products that do not provide outcomes sufficient to their costs more difficult for clinicians to access and treat patients with.
Dr Owens explains that because clinicians treat their MS patients at a population level, clinical guidelines are a necessity.
Leslie Fish, PharmD, agrees and believes that it is important that healthcare professionals receive clinical data about treatment effectiveness for certain patient populations.
Patricia K. Coyle, MD, suggests that improvements in MS disease activity biomarkers can also help clinicians make more educated decisions about treatment.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More